clinical trial · NCT07154823
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Tempus AI·—·recruiting·n = 550
Acute Myeloid Leukaemia (AML)Follicular Lymphoma ( FL)None - Observational Study
brief summary
The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.
started
Jan 27, 2026
primary completion
Nov 1, 2034
completion
Nov 1, 2035
last updated
Mar 3, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol